BCM receives multiple recognitions from the American Heart Association
Baylor Medicine, the multidisciplinary practice of Baylor College of Medicine, has received Target: BP™ Gold+ and Silver recognition, Check. Change. Control. Cholesterol™ Gold recognition and Target: Type 2 Diabetes℠ Gold recognition from the American Heart Association. These awards acknowledge the practices’ commitment to decreasing the number of Americans living with uncontrolled blood pressure, diabetes and cholesterol and to reducing the risk of heart disease and strokes.
“We appreciate the American Heart Association’s initiatives to draw attention to and drive improvements in treating hypertension, diabetes and high cholesterol, and we are honored to be recognized for our efforts in improving care for patients with these conditions,” said Dr. Daniel Murphy, chief quality officer of Baylor Medicine and medical director of the Baylor Medicine General Internal Medicine Clinic. “The large number of awards Baylor College of Medicine received this year helps validate our efforts to continually optimize the care we deliver to our patients.”
The Baylor Medicine specialties that received the Target: BP™ Gold+ Achievement Award are:
• Baylor Medicine Comprehensive Health Clinic
• Baylor Medicine Cardiology at Fannin Tower
• Baylor Medicine Medical Genetics
The Target: BP™ Gold+ award recognizes practices that demonstrate a commitment to measurement accuracy and those that achieve blood pressure control in 70% or more of adult patients with hypertension.
The Baylor Medicine specialties and clinics that received the Target: BP™ Silver Achievement Award are:
• Baylor Medicine Allergy and Immunology
• Baylor Medicine Anesthesiology
• Baylor Medicine Atherosclerosis
• Baylor Medicine Bariatric Surgery
• Baylor Medicine Cardiology
• Baylor Medicine Dermatology
• Baylor Medicine Endocrinology
• Baylor Medicine Family Medicine – Kirby
• Baylor Medicine Family Medicine – River Oaks
• Baylor Medicine Family Medicine – Fannin Tower (Texas Medical Center)
• Baylor Medicine Gastroenterology
• Baylor Medicine General Internal Medicine
• Baylor Medicine General Surgery
• Baylor Medicine Geriatrics
• Baylor Medicine Infectious Disease
• Baylor Medicine Nephrology
• Baylor Medicine Neurology
• Baylor Medicine Neurosurgery
• Baylor Medicine Ophthalmology
• Baylor Medicine Ophthalmology – Springwoods Village
• Baylor Medicine Orthopedic Surgery
• Baylor Medicine Otolaryngology
• Baylor Medicine Physical Medicine and Rehabilitation
• Baylor Medicine Plastic Surgery
• Baylor Medicine Psychiatry and Behavioral Sciences
• Baylor Medicine Pulmonary
• Baylor Medicine Rheumatology
• Baylor Medicine Thoracic Surgery
• Baylor Medicine Transition Medicine
• Baylor Medicine Urology
• Baylor Medicine Vascular Surgery
The Target: BP™ Silver award recognizes practices that have demonstrated a commitment to improving blood pressure control through measurement accuracy.
The Baylor Medicine specialties and clinics that received the Check. Change. Control. Cholesterol™ Gold Achievement Award are:
• Baylor Medicine Allergy and Immunology
• Baylor Medicine Anesthesiology
• Baylor Medicine Atherosclerosis
• Baylor Medicine Bariatric Surgery
• Baylor Medicine Cardiology
• Baylor Medicine Dermatology
• Baylor Medicine Endocrinology
• Baylor Medicine Family Medicine – Kirby
• Baylor Medicine Family Medicine – River Oaks
• Baylor Medicine Family Medicine – Fannin Tower (Texas Medical Center)
• Baylor Medicine Cardiology at Fannin Tower
• Baylor Medicine Gastroenterology
• Baylor Medicine General Internal Medicine
Baylor Medicine General Surgery
• Baylor Medicine Geriatrics
• Baylor Medicine Infectious Disease
• Baylor Medicine Nephrology
• Baylor Medicine Neurology
• Baylor Medicine Neurosurgery
• Baylor Medicine Ophthalmology
• Baylor Medicine Ophthalmology – Springwoods Village
• Baylor Medicine Orthopedic Surgery
• Baylor Medicine Otolaryngology
• Baylor Medicine Physical Medicine and Rehabilitation
• Baylor Medicine Psychiatry and Behavioral Sciences
• Baylor Medicine Pulmonary
• Baylor Medicine Rheumatology
• Baylor Medicine Thoracic Surgery
• Baylor Medicine Urology
• Baylor Medicine Vascular Surgery
The Check. Change. Control. Cholesterol™ Gold award recognizes practices that appropriately manage with statin therapy at least 70% of their adult patients at high risk of atherosclerotic cardiovascular disease.
The Baylor Medicine specialties and clinics that received the Target: Type 2 Diabetes℠ Gold recognition are:
• Baylor Medicine Allergy and Immunology
• Baylor Medicine Comprehensive Health Clinic
• Baylor Medicine Endocrinology
• Baylor Medicine Family Medicine – Kirby
• Baylor Medicine Family Medicine – River Oaks
• Baylor Medicine Family Medicine – Fannin Tower (Texas Medical Center)
• Baylor Medicine General Internal Medicine
• Baylor Medicine Geriatrics
• Baylor Medicine Nephrology
The Target: Type 2 Diabetes℠ Honor Roll recognizes healthcare organizations for providing the most up-to-date, evidence-based care for patients with type 2 diabetes who are hospitalized with heart failure, heart attack or stroke.
Target: BP™ is a national initiative formed by the American Heart Association and the American Medical Association in response to the high prevalence of uncontrolled blood pressure (BP). Target: BP helps healthcare organizations and care teams, at no cost, improve BP control rates through an evidence-based quality improvement program and recognizes organizations committed to improving BP control.
The American Heart Association created the Check. Change. Control. Cholesterol™ initiative with national support from Amgen to improve awareness, detection and management of high cholesterol for consumers, patients and healthcare professionals.
The American Heart Association and the American Diabetes Association launched the collaborative initiative called Know Diabetes by Heart™ to comprehensively combat the national public health impact of type 2 diabetes and cardiovascular disease. To bring attention to this critical high-risk population, the AHA established the Target: Type 2 Diabetes℠ Honor Roll recognition opportunity.
“Cardiovascular disease is currently the leading cause of death in the United States, and uncontrolled hypertension, diabetes and cholesterol increase the likelihood of cardiovascular complications,” Murphy said. “The use of evidence-based methods to optimize blood pressure, cholesterol and diabetes care allows us to make meaningful impacts in reducing the risk of heart attacks, strokes and other cardiovascular events, leading to longer and healthier lives for our patients.”